Letter to the Editor regarding “Integrative systems biology, transcriptomic profiling, and experimental validation reveal enterolactone as a multi-target inhibitor of metastatic signalling in triple-negative breast cancer”

IF 7.5 2区医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL

Biomedicine & Pharmacotherapy Pub Date : 2025-10-02 DOI:10.1016/j.biopha.2025.118605

Parth Aphale, Shashank Dokania, Himanshu Shekhar

引用次数: 0

查看原文本刊更多论文

关于“综合系统生物学、转录组学分析和实验验证揭示肠内酯是三阴性乳腺癌转移信号的多靶点抑制剂”的致编辑信

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Biomedicine & Pharmacotherapy 医学-药学

CiteScore

11.90

自引率

2.70%

发文量

1621

审稿时长

48 days

期刊介绍： Biomedicine & Pharmacotherapy stands as a multidisciplinary journal, presenting a spectrum of original research reports, reviews, and communications in the realms of clinical and basic medicine, as well as pharmacology. The journal spans various fields, including Cancer, Nutriceutics, Neurodegenerative, Cardiac, and Infectious Diseases.